tiprankstipranks
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market

Galmed Pharmaceuticals (GLMD) Income Statement

Compare
1,259 Followers

Galmed Pharmaceuticals Income Statement

Last quarter (Q3 2024), Galmed Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Galmed Pharmaceuticals's net income was $-1.91M. See Galmed Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -31.00K$ -35.00K$ -42.00K$ -39.00K$ -35.00K
Operating Expenses
$ -7.49M$ 17.65M$ 32.88M$ 30.21M$ 22.38M
Depreciation and Amortization
$ 31.00K$ 35.00K$ 42.00K$ 39.00K$ 35.00K
EBITDA
$ -6.87M$ -17.62M$ -32.84M$ -30.17M$ -22.34M
Operating Income
$ 7.49M$ -17.65M$ -32.88M$ -30.21M$ -22.38M
Other Income/Expenses
$ -14.40M$ -215.00K$ 414.00K$ 1.44M$ 1.92M
Pretax Income
$ -6.91M$ -17.87M$ -32.47M$ -28.77M$ -20.46M
Net Income
$ -6.91M$ -18.57M$ -31.95M$ -27.61M$ -18.54M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -30.05$ -11.08$ -19.48$ -19.46$ -13.17
Diluted EPS
$ -29.95$ -11.08$ -19.48$ -19.46$ -13.17
Weighted Average Shares Outstanding
230.00K 1.68M 1.64M 1.42M 1.41M
Weighted Average Shares Outstanding (Diluted)
230.79K 1.68M 1.64M 1.42M 1.41M
Currency in USD

Galmed Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis